Navigation Links
Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance
Date:5/9/2008

igation

settlements - 7,350

ADJUSTED CASH NET INCOME $ 82,866 $ 58,359

WARNER CHILCOTT LIMITED

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands of U.S. dollars)

(Unaudited)

As of As of

March 31, 2008 December 31, 2007

ASSETS

Current assets:

Cash & cash equivalents $ 16,239 $ 30,776

Accounts receivable, net 84,798 65,774

Inventories 60,737 54,031

Prepaid expenses & other current

assets 79,976 65,735

Total current assets 241,750 216,316

Other assets:

Property, plant and equipment, net 59,551 57,453

Intangible assets, net 1,279,714 1,329,427

Goodwill 1,250,324 1,250,324

Other non-current assets 29,936 31,454

TOTAL ASSETS $2,861,275 $2,884,974

LIABILITIES

Current liabilities:

Accounts payable $ 19,366 $ 17,883

Accrued expenses & other current

liabilities 143,343 196,362

Current portion of long-term debt 8,284 8,284

Total current liabilities 170,993 222,529

Other liabilities:

Long-term debt, excluding current

portion 1,189,884
'/>"/>

SOURCE Warner Chilcott Limited
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related biology technology :

1. Warner Chilcott Announces Receipt of Paragraph IV Certification Notice
2. Warner Chilcott Announces New Information in USPTO Reexamination of Taclonex Patent
3. Warner Chilcott Announces Earnings Release Date and Conference Call for Third Quarter 2007 Financial Results
4. Warner Chilcott and Watson Pharmaceuticals Announce Launch of Tilia(TM) Fe
5. Warner Chilcott Announces Earnings Release Date and Conference Call for Fourth Quarter and Full Year 2007 Financial Results
6. Warner Chilcott Reports Operating Results for the Quarter and Year ended December 31, 2007
7. Warner Chilcott Reports the Death of Its Director James Andress
8. Mark Whitacre, Ph.D. Promoted at Cypress Systems, Inc. and a Warner Brothers Movie to Be Filmed About Him
9. Warner Chilcott Announces Earnings Release Date and Conference Call for First Quarter 2008 Financial Results
10. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
11. QMed, Inc. Reports July Medicare SNP Enrollments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/9/2008)...educed operating costs drive solid ...a, May 9 /- Warner Chilcott...lts for the quarter ended,March 31, 2008. Revenue ...,million, an increase of 5.1%, over the prior year...evenue were the net sales of our promoted,products...
(Date:5/9/2008)...ssions Include Presentations from Inst...taxis to Feature New Odyssey Information Managemen...cts in Booth 304, ST. LOUIS, May 9 /PRNewswire-Fi...nced today that its participation at Heart Rhythm ...chieved as the only provider of fully,automated, r...
(Date:5/9/2008)...ks key milestones with insulin and Apo ... TSX symbol: SBS, CALGARY, May 9 /PRNewswi... a biotechnology company developing a portfolio of...ular diseases, today announced its,2008 first quar...hts, - Prepared pilot scale quantities of insul...
(Date:5/9/2008)...FirstCall/ -- Northwest,Biotherapeutics, Inc. (AIM...announced that Al Rajhi Holdings W.L.L. ("Al Rajhi...6 2008, to provide NWBT with debt financing in,the...e terms of the Loan, Northwest will receive US$4.0...e in the principal amount of,US$4,240,000 (reflect...
Breaking Biology Technology:Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 2Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 3Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 4Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 5Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 6Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 7Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 8Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 9Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 10Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 11Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 12Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 13Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 14Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 15Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 16Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 17Stereotaxis' Market Leadership Highlighted at Heart Rhythm 2008 2Stereotaxis' Market Leadership Highlighted at Heart Rhythm 2008 3Stereotaxis' Market Leadership Highlighted at Heart Rhythm 2008 4Stereotaxis' Market Leadership Highlighted at Heart Rhythm 2008 5SemBioSys announces first quarter 2008 financial and operational results 2SemBioSys announces first quarter 2008 financial and operational results 3SemBioSys announces first quarter 2008 financial and operational results 4SemBioSys announces first quarter 2008 financial and operational results 5SemBioSys announces first quarter 2008 financial and operational results 6SemBioSys announces first quarter 2008 financial and operational results 7SemBioSys announces first quarter 2008 financial and operational results 8SemBioSys announces first quarter 2008 financial and operational results 9SemBioSys announces first quarter 2008 financial and operational results 10SemBioSys announces first quarter 2008 financial and operational results 11SemBioSys announces first quarter 2008 financial and operational results 12Northwest Secures US$4.0 Million in Debt Financing 2Northwest Secures US$4.0 Million in Debt Financing 3
..., In this BioPharm,International excl...,science and,manufacture of his,companys innov..., Dr.Zhaohui Peng is the chairman,chief...o GeneTech Co., Ltd., , Langshen Road, Sh..., 0755.2696.8818, , fax: 0755.26...
...y Chris Julien; Reprinted with permission from Ame... Scaling up from spinners, T-flasks or shaker... reap the benefits of saving time.,As an example... 5-L bioreactor has been shown to produce the equi...-flasks 1 . Moreover, a bioreactor requires only o...
..., , Introduction , ...cumenting,simple protocols for culturing cells i...ystem. The modular,BioFlo 110 is offered with a ...s to enable growth of a wide variety,of cultures...bacterial cells. Complete kits are also available....
... Michael Olive, Ph.D. , Molecular Biology... Lincoln, NE 68504 , , ABSTRACT...developing biomedical technology that enables the ... of a living animal. While several optical imaging...oluminescent reporter systems have shown utility i...
Other Biology Technology:The Genesis of Gendicine: The Story Behind the First Gene Therapy 2The Genesis of Gendicine: The Story Behind the First Gene Therapy 3The Genesis of Gendicine: The Story Behind the First Gene Therapy 4The Genesis of Gendicine: The Story Behind the First Gene Therapy 5The Genesis of Gendicine: The Story Behind the First Gene Therapy 6The Genesis of Gendicine: The Story Behind the First Gene Therapy 7The Genesis of Gendicine: The Story Behind the First Gene Therapy 8The Genesis of Gendicine: The Story Behind the First Gene Therapy 9The Genesis of Gendicine: The Story Behind the First Gene Therapy 10The Genesis of Gendicine: The Story Behind the First Gene Therapy 11The Genesis of Gendicine: The Story Behind the First Gene Therapy 12The Genesis of Gendicine: The Story Behind the First Gene Therapy 13The Genesis of Gendicine: The Story Behind the First Gene Therapy 14The Genesis of Gendicine: The Story Behind the First Gene Therapy 15Scaling-Up from Spinners, T-Flasks & Shakers: A versatile bioreactor for mammalian and microbial cells 2Scaling-Up from Spinners, T-Flasks & Shakers: A versatile bioreactor for mammalian and microbial cells 3Scaling-Up from Spinners, T-Flasks & Shakers: A versatile bioreactor for mammalian and microbial cells 4Scaling-Up from Spinners, T-Flasks & Shakers: A versatile bioreactor for mammalian and microbial cells 5Scaling-Up from Spinners, T-Flasks & Shakers: A versatile bioreactor for mammalian and microbial cells 6Insect Cell Culture Using a BioFlo 110 Benchtop Bioreactor 2Insect Cell Culture Using a BioFlo 110 Benchtop Bioreactor 3Insect Cell Culture Using a BioFlo 110 Benchtop Bioreactor 4Insect Cell Culture Using a BioFlo 110 Benchtop Bioreactor 5Insect Cell Culture Using a BioFlo 110 Benchtop Bioreactor 6Near Infrared Technology and Optical Agents For Molecular Imaging 2Near Infrared Technology and Optical Agents For Molecular Imaging 3Near Infrared Technology and Optical Agents For Molecular Imaging 4Near Infrared Technology and Optical Agents For Molecular Imaging 5Near Infrared Technology and Optical Agents For Molecular Imaging 6Near Infrared Technology and Optical Agents For Molecular Imaging 7
(Date:5/9/2008)... the May 2008 Pediatric Academic Societies and Asi...dicate that childhood and adolescent obesity negat... relates to cardiac health. , Obesity has been i...ears and obesity in adults has been linked to card...ildren is also increasing and many cardiovascular ...
(Date:5/9/2008)...apped their comfortable offices for one of the mos... out a challenging field campaign that is seen as ...e mission CryoSat will be as accurate as possible....any and Canada, are currently in the middle of Cry...nsive three-week experiment programme in the far n...
(Date:5/8/2008)... (UM) students have received prestigious Graduate ...ndation (NSF) for their doctoral work on coral ree... receive three years of support for their work in ...rofessor in the Division of Marine Biology and Fis...spheric Science. In addition, a third student ent...
(Date:5/8/2008)...predict aspects of fish diversity in specific rive...y drive a comprehensive suite of fish biodiversity...has been elusive. , Now a group of researchers, i...Fagan, reports success using a so-called neutral m...issippi-Missouri River System. Their study appears...
Breaking Biology News(10 mins):Study supports reason for concern in childhood and adolescent obesity 2Scientists endure Arctic for last campaign prior to CryoSat-2 launch 2Scientists endure Arctic for last campaign prior to CryoSat-2 launch 3Everything's coming up corals 2Everything's coming up corals 3Model successfully predicts large river system fish diversity 2LMS Third Quarter 2008 Financial Results Q3 Revenue Increases 88 25 to 241 0 Million YTD Revenue Increases 87 25 to 242 6 Million 11739 1LMS Third Quarter 2008 Financial Results Q3 Revenue Increases 88 25 to 241 0 Million YTD Revenue Increases 87 25 to 242 6 Million 11739 2LMS Third Quarter 2008 Financial Results Q3 Revenue Increases 88 25 to 241 0 Million YTD Revenue Increases 87 25 to 242 6 Million 11739 3LMS Third Quarter 2008 Financial Results Q3 Revenue Increases 88 25 to 241 0 Million YTD Revenue Increases 87 25 to 242 6 Million 11739 4Transplant Community Unites to Educate Capitol Hill Staffers About the Gift of Life 11734 1Transplant Community Unites to Educate Capitol Hill Staffers About the Gift of Life 11734 2Dynatronics to Release Second Quarter Results Thursday February 14 2008 3B Conference Call Set for 4 3A30 p m ET 11729 1Gen Probe to Webcast Presentation at Deutsche Bank Small and Mid Cap Growth Conference 11724 1Gen Probe to Webcast Presentation at Deutsche Bank Small and Mid Cap Growth Conference 11724 2
...rsity of California, Riverside has used chemical g...e ability of plants to alter their direction of gr... gravitropism. , The researchers screened a librar... as chemical genomics, to identify those that coul... on plant growth, which is closely linked to the m...
...n textbooks, are essential for eukaryotic cells--i...of energy as they use oxygen. However, some eukary...s--such as Entamoeba histolytica, the causal agent...re too oxygen poor to support this process. Nevert...ious organelle, called a mitosome, that is evoluti...
... student may have figured out why rates of extinct...rine life during one of the greatest ice ages of t...290 million years ago, late in the Paleozoic Era. ...rms that did survive during this era were singular...rature and sea levels. Those that were not died in...
...ntifies 34 regions worldwide where 75 percent of t...phibians survive within habitat covering just 2.3 ... to the combined areas of the five largest U.S. st...t of the Earth,s surface, an area equivalent in si...sis shows that an estimated 50 percent of all vasc...
Other Biology News:Researchers discover chemical compounds that affect plant growth 2Low level of extinction during ice age linked to adaptability 2Biodiversity hotspots identify conservation priorities 2Biodiversity hotspots identify conservation priorities 3Biodiversity hotspots identify conservation priorities 4Biodiversity hotspots identify conservation priorities 5
Request Info
Request Info
Request Info
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays.
Biology Products: